The effects of cinnarizine on menopausal symptoms in women

Climacteric

Volumn 14, Issue 4, 2011, Pages 492-496

  Cezarino, P Y ^a   Bagnoli, V R ^a   Fonseca, A M ^a   Soares, J M ^b   Baracat, E C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cinnarizine; Hot flushes; Kupperman menopausal index; Night sweats; Quality of life; Treatment of menopausal symptoms

Indexed keywords

CINNARIZINE; FOLLITROPIN; PLACEBO;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTHRALGIA; ARTICLE; BODY MASS; CLIMACTERIUM; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLITROPIN BLOOD LEVEL; FORMICATION; HEADACHE; HEART PALPITATION; HIP CIRCUMFERENCE; HOT FLUSH; HUMAN; INSOMNIA; KUPPERMAN MENOPAUSAL INDEX; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MELANCHOLIA; MENOPAUSAL SYNDROME; MYALGIA; NERVOUSNESS; PARESTHESIA; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VAGINAL DRYNESS; VERTIGO; WAIST CIRCUMFERENCE; WEAKNESS;

AGED; CINNARIZINE; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PLACEBOS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; VAGINAL DISEASES;

EID: 79960468606     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.553973     Document Type: Article

References (23)

1. Nelson H. Menopause. Lancet 2008; 371: 760-70 (Pubitemid 351288876)
2. Silva Filho CR, Baracat EC, Conterno LO, Haidar MA, Ferraz MB. Sintoma climatericos e qualidade de vida de vida: validação do questionário da saúde da mulher. Rer Saude Publica 2005;39:333-9
3. Hulley S. Effects of estrogen or progestin regimes on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/progestin Interventions (PEPI). JAMA 1995;273:199-208
4. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280: 605-13 (Pubitemid 28502636)
5. WHI Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-33
6. Keenam NL, Keenan NL, Fugh-Berman A, Browne D, Kaczmarc-zyk J, Hunter C. Severity of menopause symptoms and use of both conventional and complementary alternative therapies. Menopause 2003;10:507-15 (Pubitemid 40228144)
7. Badalotti M. Climatério: tratamento não hormonal dos sintomas vasomotores. Sci Med 2004;4:71-6
8. Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 2007;276:463-9 (Pubitemid 47415761)
9. Natchtigall LE. Therapy: nonhormonal treatment of hot flashes: a viable alternative? Nat Rev Endocrinol 2010;6:66-7
10. Cirek Z, Schwarz M, Baumann W, Novotny M. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhy-drinate versus betahistine in the treatment of otogenic vertigo: a double-blind, randomised clinical study. Clin Invest Drug 2005;25:377-89 (Pubitemid 41019985)
11. Togha M, Rahmat Jirde M, Nilavari K, et al. Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. J Headache Pain 2008;9: 77-82
12. Rossi P, Fiermonte G, Pirelli F. Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial. Funct Neurol 2003;18:155-9 (Pubitemid 37526810)
13. Fonseca AM, Guarnieri Netto C, Melo NR. Efeito da cinarizina na síndrome do climatério. Rev Bras Ginecol 1985;95:313-16
14. Fonseca AM, Guarnieri Netto CG, Mello NR, et al. Estudo laroratorial do efeito da vinarizina na síndrome do climatério. Rev Bras Clin Terap 1987;16:92-5
15. Freedmann RR. Pathophysiology and treatment of hot flashes. Semin Reprod Med 2005;23:117-25
16. Brunner RL, Aragaki A, Barnabei V, et al. Menopause symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause 2010;17:946-54
17. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 Position statement of The North American Menopause Society. Menopause 2010;17:242-55
18. Hulley SB. The WHI estrogen-alone trial-do things look any better. JAMA 2004;291:1769
19. Dodin S, Lemay A, Jacques H, Légaré F, Forest JC, Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005;90:1390-7 (Pubitemid 40463994)
20. Grady D, Cohen B, Tice J, Kristol M, Olyale A, Sawaya GF. Ineffectiveness of sertralina for treatment of menopause hot flushes: a randomized controlled trial. Obstet Gynecol 2007;109: 823-30 (Pubitemid 46559068)
21. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopause symptoms: a systematic review. Obstet Gynecol 2004;104:824-36 (Pubitemid 40458814)
22. Castelo Branco de Luca A, Maggio da Fonseca A, Carvalho Lopes CM, Bagnoli VR, Soares JM Jr, Baracat EC. Acupuncture-ameliorated menopausal symptoms: single-blind, placebo-controlled, randomized trial. Climacteric 2011;14:140-5
23. Hahn A, Sejna I, Stefflova B, Schwarz M, Baumann W. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study. Clin Invest Drug 2008;282:89-99 (Pubitemid 351209486)